The Laparoscopic Power Morcellators Market is
estimated to be valued at US$ 113.21 Mn in 2023 and is expected to exhibit a
CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new
report published by Coherent Market Insights.
Market Overview:
Laparoscopic power morcellators are surgical devices used to divide tissue and
remove organs such as uterus or fibroids through small incisions in minimally
invasive laparoscopic procedures. These devices morcellate (cut) the tissue
into small fragments that can be easily removed through the small openings.
Some key applications of laparoscopic power morcellators include myomectomy,
hysterectomy, and removal of other growths or cysts from the pelvic region.
They offer various benefits over traditional open surgeries such as reduced
blood loss, shorter hospital stay, lesser post-surgery pain and faster
recovery.
Market Dynamics:
Increasing prevalence of gynecological disorders such as uterine fibroids among
women is a major driver boosting demand for minimally invasive laparoscopic
procedures involving power morcellators. According to the Uterine Fibroids
Report published by Granular, inc. in 2019, uterine fibroids affect an
estimated 70-80% of women by the age of 50 in the United States. Moreover, growing
geriatric population who are more prone to such disorders is another factor
propelling the laparoscopic power morcellators market growth. However, risk of
morcellation leading to dissemination of occult malignancy is a challenge for
market players. Various advances in technology to mitigate this risk such as
containment bag devices and laparoscopic morcellators with advanced tissue
morcellation abilities are opportunities that can further stimulate the market
over the forecast period.
Segment
Analysis
The global laparoscopic power morcellators
market is dominated by gynecological procedures segment. This segment holds the
largest market share owing to the rising number of hysterectomies performed
globally using minimally invasive procedures. According to the statistics,
hysterectomy is one of the most common surgical procedures performed in women,
accounting for over 600,000 procedures annually in the United States alone.
PEST Analysis
Political: Regulations by various government bodies on usage of power morcellators
during laparoscopic hysterectomies or myomectomies owing to risk of upstaging
uterine cancers.
Economic: Rising healthcare expenditure coupled with growing adoption of
minimally invasive procedures is fueling the market growth.
Social: Increasing awareness about benefits of minimal invasive surgeries and
growing geriatric population undergoing various medical procedures.
Technological: Advancements in power morcellators with improved blades and
motor systems has increased safety and efficiency of procedures.
Key Takeaways
Global
Laparoscopic Power Morcellators Market Size is expected to witness high
growth at a CAGR of 5.3% over the
forecast period of 2023 to 2030. The market was valued at US$ 113.21 Mn in 2023
and is anticipated to reach US$ 164.21 Mn by 2030. Factors such as growing
number of laparoscopic hysterectomy and myomectomy procedures performed
globally is driving the market.
Regionally, North America dominates the global market and is expected to grow
at a high CAGR during the forecast period. This is attributed to factors such
as rising incidence of uterine fibroids, established healthcare infrastructure
and high adoption of minimally invasive surgeries in the region.
Key players operating in the laparoscopic power morcellators market are LiNA
medical, Blue endo, Johnson and Johnson, Hangzhou kangji medical instruments,
WISAP medical technology, Zhejiang geyi medical instrument, Karl storz GmbH,
Medtronic, Richard wolf GmbH, Lumenis (Boston Scientific Corporation), Nouvag
AG, RUDOLF Medical GmbH, and Olympus Corporation. Some of the key players are
focusing on new product launches and geographical expansion to consolidate
their market presence.
Comments
Post a Comment